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Correlation of renal histology with outcome in children with lupus
nephritis. We assessed renal histological features in 20 children with
diffuse proliferative lupus nephritis (DPLN) to determine whether they
were useful in predicting clinical outcome. Renal biopsies were ana-
lyzed by assigning scores indicating an activity index (Al) and chronic-
ity index (CI). Clinical assessment of renal function at biopsy and
outcome. were graded according to urinalysis, serum creatinine, need
for dialysis and/or transplantation, and/or death from end—stage renal
failure. Renal function at biopsy correlated significantly with Al and Cl.
Serum complement (C3 and C4) correlated significantly with Cl but not
with Al. The usefulness of the clinical grading system was confirmed in
ten patients who underwent repeat biopsies. Of these, four converted
from DPLN to mesangial or membranous lupus and showed improve-
ment in their grade, while only one of the six with DPLN on both
biopsies improved. After a mean follow—up of 4.0 years, 14 of the 20
patients showed clinical improvement, four were unchanged, and two
were worse. Cl predicted clinical outcome (P < 0.01) but Al did not.
Histologic scores of Al and Cl obtained from renal biopsies showing
DPLN may be useful in predicting therapeutic responses and designing
prospective clinical trials to determine optimum management of chil-
dren with DPLN.
Renal involvement is a major cause of morbidity and mortal-
ity in systemic lupus erythematosus (SLE). Consequently, in
some centers, renal biopsies are performed on all patients with
SLE and the morphological findings are used as a guide for
therapy and prognosis. In other centers, therapy and prognosis
are based entirely on clinical assessment of renal function.
Because of this difference in practice, we analyzed the renal
biopsies of 20 children with SLE that showed diffuse prolifer-
ative lupus nephritis (DPLN), using histologic scores based on
an activity index (A!) and a chronicity index (CI). We corre-
lated these scores with renal function and serum levels of C3
and C4 at the time of renal biopsy and at outcome to determine
whether the renal biopsy was useful in predicting the course of
SLE.
Methods
The medical histories of all children with SLE who were
hospitalized at The Hospital for Sick Children (HSC), Toronto,
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between 1970 and 1984 and had renal biopsies showing DPLN
were reviewed. We elected to include only patients with DPLN
since this is the worst form of SLE and the most difficult to
treat. In addition, decisions about therapy are critical for
management of DPLN, yet there is considerable controversy
about treatment. Our goal was to determine the relationship of
renal biopsies to renal function and outcome in DPLN patients,
whose course must be considered to be guarded.
All of the children in this study fulfilled at least four of the
criteria for diagnosis of SLE established by the American
Rheumatism Association [1]. Renal status was evaluated at the
time of renal biopsy to assess the extent of kidney involvement
from lupus. Assessment of outcome was based on the most
recent physical examination, urinalysis, renal function tests and
SLE serology.
All of the children with SLE described in the present paper
were treated at the onset of their disease with daily oral
prednisone in a dose of 2 mg/kg body wt per day (maximum 80
mg) given in 3 to 4 divided doses, without regard for the changes
seen on renal biopsy. After four to eight weeks, the prednisone
was gradually reduced to alternate day therapy. All of the
children also received azathioprine as a prednisone—sparing
drug in a single daily dose of I to 2 mg/kg body wt. Depending
on disease activity, prednisone was reduced to the lowest dose
that would maintain a biochemical and clinical remission. A
relapse was usually indicated by an increase in proteinuria and
an active urinary sediment associated with a fall in serum C3
and/or C4 and increasingly positive serology (ANF or anti-
DNA). Relapses were managed by daily prednisone in divided
doses, followed by gradual tapering to alternate day therapy. In
occasional cases, bolus intravenous methylprednisolone (10
mg/kg body wt per day x 3 days) or plasmapheresis was used.
The grading system to measure renal function at the time of
renal biopsy and at outcome was employed previously [21, and
consisted of simple measurements of renal function which could
easily be obtained from the patients' charts: grade 1, normal
urinalysis or up to trace proteinuria and normal serum (true)
creatinine (that is, 1.0 mg/dliter); grade 2, proteinuria of I to
2 + (30 to 100 mg/dliter), or hematuria or occasional granular or
cellular casts, and a normal serum creatinine; grade 3, protein-
uria of 3 to 4+ (> 300 mg/dliter) and a serum creatinine (> 1.0
but 1.4 mg/dliter); grade 4, nephrotic range proteinuria
(> 100 mg/kg body wt per day) and/or an abnormal serum
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creatinine (> 1.4 mg/dliter); and grade 5, institution of dialysis
and/or transplantation or death from end—stage renal failure.
Children who fell by at least one grade, remained unchanged, or
rose by at least one grade between the time of renal biopsy and
outcome were considered to have shown improvement, no
change, or a worsening of their renal status respectively.
Closed renal biopsies were performed at the time of diagnosis
of SLE, before treatment was begun, in nine patients. Nine
other patients had received prednisone for less than one week,
while the remaining two had been taking prednisone for more
than one month prior to biopsy. Biopsies containing at least six
glomeruli were examined by two pathologists (MS and RB)
using light microscopy (LM); neither pathologist had any
knowledge of the patients' renal function or serum levels of C3
or C4. Both qualitative (modified World Health Organization
[WHO]) and semi-quantitative (Al and CI) classifications were
used to analyze the renal biopsies [3—5]. The original WHO
classification of lupus nephritis (normal, mesangial, focal seg-
mental proliferative, diffuse proliferative, and membranous) has
been modified slightly to include these as well as an advanced
sclerosing category [3]. The modified classification also stressed
that some cases of lupus nephritis could be active, active and
inactive, or inactive only, and that one form of nephritis might
convert into another. DPLN (class 4) was divided into the
following categories: 4A, no segmental lesions; 4B, active
necrotizing lesions; 4C, active and sclerotic lesions; and 4D,
sclerotic lesions. A semi-quantitative pathologic scoring sys-
tem, based on methods derived originally by Pirani, Pollak, and
Schwartz [4] and adapted later at the National Institute of
Health [5], was also used. This system involved assignment of
scores of 0, 1,2, or 3 to individual morphological features of the
biopsy.
The LM features which were evaluated included: 1) mesan-
gial and endothelial cell proliferation, 2) leukocyte exudation, 3)
karyorrhexis and/or fibrinoid necrosis, 4) cellular crescents, 5)
hyaline deposits, 6) interstitial inflammation, 7) glomerulosclero-
sis, 8) fibrous crescents, 9) tubular atrophy, and 10) interstitial
fibrosis. These features were assessed using slides stained with
hematoxylin and eosin, hematoxylin phloxine and saffron, and
Masson trichrome. An Al was calculated on the basis of the
sum of the first six items. The scores for karyorrhexis/fibrinoid
necrosis and cellular crescents were multiplied by two so that
the total maximum score for Al was 24. The sum of the last four
items provided a maximum score of 12 for the CI.
The renal biopsies were also processed by immunofluores-
cence (IMF) and electron microscopy (EM). IMF was per-
formed using fluorescent—labelled anti-IgG, anti-IgM, anti-IgA,
and anti-C3 antisera. EM was performed using tissue which had
been fixed in universal fixative, dehydrated in graded ethanols,
embedded in Epon, cut using a cryostat, and stained with osmium
tetroxide and uranyl acetate. The results of the LM examination
were used to reach a diagnosis of DPLN on the renal biopsies,
while data from IMF and EM provided confirmation.
Statistical analysis was performed using non-parametric tests
of significance (that is, the Spearman—Rank correlation coeffi-
cient and the Mann—Whitney—U-test) [6]. P values > 0.05 were
considered not significant. To determine the influence of vari-
ous factors on outcome, the patients were divided into two
groups on the basis of sex, mean serum levels of C3 and C4
obtained at the time of renal biopsy, the mean pathological
Table 1. Clinical features in 20 children at first renal biopsy showing
diffuse proliferative lupus nephritis and at outcome'
Clinical features
Time of biopsy
number %
Outcome
number %
A) Renal features
Proteinuria
present 17 (85) 12 (60)
3.0 gm/24 hr 7 (35) 2 (10)
Hematuria 8 (40) 0 (0)
Hypertension 8 (40) 0 (0)
B) Renal status
Grade 1 0 (0) 7 (35)
Grade 2 4 (20) 3 (15)
Grade 3 4 (20) 5 (25)
Grade 4 12 (60) 4 (20)
Grade 5 0 (0) 1 (5)
C) Extra—renal features
Arthritis 9 (45) 0 (0)
CNS 2 (10) 0 (0)
Skin 15 (75) 2 (10)
Serositis 5 (25) 0 (0)
D) Therapyc
Nil — 3 (15)
Prednisone — 8 (40)
Prednisone & azathioprine — 8 (40)
Plasmapharesis — 1 (5)
E) Renal biopsiesd
WHO 4A 3 (15)
4B 12 (60)
4C 5 (25)
a Mean serum creatinine (± sn was 1.1 0.4mg/dliter at biopsy and
1.5 0.4 at outcome.
b Serum levels of C3 were 43 16 mg/dliter at biopsy and 90 30
mg/dliter at outcome. The C4 levels were 7 2.6 mg/dliter at biopsy
and 17 7 mg/dliter at outcome.
C Therapy at time of biopsy is described in the Methods.d Renal biopsies not done at outcome.
scores of Al and CI, and the mean scores for the individual
histological features of the Al and CI.
Results
Clinical features of the group and individual children at first
renal biopsy
The 20 children (mean age 13.7 years, range 6 to 18 years)
included nine boys and 11 girls (Table 1). At the time of biopsy,
most (17 patients, 85%) showed proteinuna ( 3.0 g/24 hr in 7),
while hematuria and hypertension were each seen in eight.
Serum creatinine was  1.4 mg/dliter in five children. Renal
function was classified as grade 2 in four children, grade 3 in
four, and grade 4 in 12 children. The grades for each child's
renal function at biopsy are shown in Table 2. Extra—renal
manifestations of SLE, including articular, neurological, cuta-
neous, and serosal signs and symptoms, occurred in ten to 75%
of the children. Active disease was indicated by reduced mean
serum levels of C3 and C4 (43 16 and 7 2.6 mg/dliter
respectively).
Pathological features of the entire group and individual
children at first renal biopsy
Renal biopsies of three children showed DPLN class 4A (no
segmental lesions), those for 12 showed class 4B (with active
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Table 2. Renal biopsy findings and grade of renal function in 20 children with lupus nephritis
Patient WHO
Biopsy 1
Al Cl Biopsy I
Grade
-
Outcome WHO
Biopsy 2
Al Cl
Grade
Time between
biopsies, monthsBiopsy 2 Outcome
I 4B 8 0 3 I
2 4A 8 0 3 2
3 4B 11 3 4 3
4 4A 3 1 2 I
5 4B 9 0 4 1
6 4C II 8 4 1
7 4C 16 8 4 2
8 4B 13 3 4 3
9 48 13 3 3 3
10 48 II 0 2 2
II 4B 16 3 4 I 2 0 0 I I 33
12 4B 9 5 4 3 4D 5 9 3 3 32
13 48 19 4 4 2 2 0 0 2 2 18
14 4B 6 0 2 I 2 0 0 I I 33
15 4C II 5 4 4 4D 6 9 4 4 31
16 4B 9 3 4 4 4B 8 3 4 4 27
17 4A 7 I 4 3 5 0 0 3 3 26
18 4C 9 5 2 5 4C 12 7 4 5 24
19 4B 9 2 4 I 4D 6 7 4 I 48
20 4C 13 6 3 4 40 12 10 4 4 30
Al/grade
Cl/grade
Al/Cl
C3/grade
C4/grade
C3/C4
C3/Al
C3/CI
C4/A1
C4/C1
Serum creatinine/grade
Serum creatinine/Al
Serum creatinine/CI
necrotizing lesions, including disruption of capillary walls,
glomerular cell proliferation, polymorphs, karyorrhexis,
fibrinoid necrosis, hematoxylin bodies, cellular crescents, wire
loops, hyaline thrombi, fibrin thrombi, and segmental fibrin
deposition), while the remaining five showed class 4C (active
and sclerotic lesions). The WHO pathological category and the
Al and CI of the renal biopsies of individual children are shown
in Table 2.
Clinicopathologic correlations at first renal biopsy
Using the Spearmann—Rank correlation coefficient, there was
a significant correlation between the Al and Cl on the one hand
and the grade of lupus nephritis on the other, but not between
the serum levels of C3 or C4 (obtained at renal biopsy) and the
grade (Table 3). In addition, C3 and C4 correlated with each
other and with the Cl but not with the Al. Finally, the serum
creatinine correlated with the grade and with the CI but not the
Al.
Clinical and pathological features of children undergoing
repeat renal biopsies
Ten of the children underwent repeat renal biopsies, eight for
purposes of clinical follow—up because they showed either
improvement or deterioration, and two because they were part
of a prospective study of therapeutic agents in SLE. Of the ten,
three showed conversion to mesangial and one to membranous
lupus nephritis (patients Il, 13, 14, 17), while six (patients 12,
15, 16, 18, 19, 20) still showed DPLN on a second biopsy (Table
2). At the time of the second biopsies, all children converting
from DPLN to either mesangial or membranous lupus showed
an improvement in their grade relative to the first biopsy. In
contrast, only one of the six with DPLN on both biopsies
showed an improved grade (patient 12), three had a similar
grade (patients 15, 16, 19), and two were worse (patients 18, 20).
The child whose grade improved showed a fall in Al but a rise
in Cl. Of those with similar grades, two behaved similarly and
the other showed a slight fall in Al and no change in CI. The
children whose grades became worse showed either an increase
or slight fall in A! and a worse CI. Therefore, there was a
reasonably good correlation between change in grade and
change in Al and CI in the children undergoing repeat renal
biopsies.
Clinical features of the group and individual children at
outcome
The mean follow—up time of the 20 children was 4.0 years
(range Ito 12 years). At outcome, 12 showed proteinuria ( 3.0
g/dliter in two) but none had hematuria or hypertension (Table
1). The serum creatinine was  1.4 mg/dliter in four. Renal
function at outcome showed improvement in that ten (50%) of
the children were now in grades 1 or 2, as opposed to four at
initial biopsy. One child had died. Only two of the children had
cutaneous SLE; no other extrarenal manifestations of SLE
were present. Mean serum levels of C3 and C4 (90 30 and 17
7 mg/dliter respectively) were now more than twice as high
Table 3. Correlations in 20 children at first renal biopsy showing
diffuse proliferative lupus nephritis
Spearman—Rank
correlation
Parameters coefficient
+ 0.41
+ 0.46
+0.23
+0.24
+ 0.23
+0.54
—0.32
+0.52
—0.15
+0.42
+0.63
+ 0.23
+ 0.47
P value
<0.05
<0.05
NS
NS
NS
<0.05
NS
<0.05
NS
<0.05
<0.01
NS
<0.05
Renal biopsies in DPLN 1069
as they had been at initial renal biopsy. Treatment at outcome
invariably involved a lower dose of daily or alternate day
prednisone.
Correlation between clinical and pathological features at
initial renal biopsy and the time of follow—up with outcome
Between the initial renal biopsy and the outcome, 14 children
showed an improved, four a similar, and two a worse grade
(Table 2). Outcome was not predicted by the sex of the child, a
reduced serum level of C3 or C4, the time of follow—up, the total
pathologic score, or the A! at initial biopsy (Mann—Whitney—U-
test) (Table 4). However, aCt  3 was predictive of progression
to a more severe grade (P < 0.01). The components of the CI
which proved to be predictive were glomerulosclerosis (P <
0.01) and interstitial fibrosis (P < 0.05).
Discussion
Our goal in the present study was to determine whether there
was a correlation between the features of DPLN on renal
biopsies in children and the clinical outcome, as shown previ-
ously in adults [7]. Although lupus nephritis in children and
adults has many similar clinical features, SLE demonstrates a
number of features, such as lymphadenopathy and splenomeg-
aly, which are more prevalent in children, suggesting that there
may be significant qualitative differences in these age groups.
Furthermore, in our study, renal biopsies showed that many of
the children already had a high CI even though their SLE was
of short duration, a situation not previously described in adults.
Since all of our patients were treated with prednisone and
azathioprine according to a protocol, these agents presumably
exerted a similar influence on A! and CI in all patients.
We used a previously described grading system [2] which
allowed analysis of all patients with DPLN rather than only
those progressing to end-stage renal failure as in previous
reports [8—11]. In our experience, most children with DPLN do
not progress to chronic or end—stage renal failure. The reliabil-
ity of our grading system was supported by the significant
correlation of grade with Al, CI, and serum creatinine, and the
improvement in grade of all patients converting from DPLN to
mesangial or membranous lupus on repeat biopsies. In contrast,
improvement occurred in only one of the six patients with
DPLN on both biopsies.
The children with DPLN described in this paper showed a
number of pathological and clinical features which deserve
comment. First, the initial renal biopsies of our patients gener-
ally showed high values for CI ( 3 in 12 patients), even though
most of these biopsies were performed at or close to the onset
of their disease. This is at variance with other experience in
adult DPLN. On the other hand, SLE may occur in an insidious
fashion with non-specific symptoms, perhaps accounting for the
substantial progression of this disease in children before a
diagnosis has been made. Indeed, some of the children in our
study did appear to have persistently active renal disease
despite having received continuous therapy with prednisone
and azathioprine. In addition, our hospital is a tertiary referral
center for pediatric nephrology and our patients may represent
an aggressive subgroup of SLE patients with chronic renal
changes early on in their disease. In the ten children undergoing
repeat renal biopsies, the A! diminished in nine (90%), while the
Parameter
Sex male
female
C3 <43 mgldliter
43 mg/dliter
C4 < 7 mgldliter
7 mg/dliter
Time of follow—up
<4.0 years
4.0 years
Total pathologic score
(Al + Cl)
<13.9
13.9
Al <10.6
lO.6
Glomerular cell
proliferation
<2.35
2.35
Leukocyte exudation
<1.5
 1.5
Karyorrhexis/fibrinoid
necrosis
<2.1
2.1
Cellular crescents
<1.51.5
Hyaline deposits
<2.1
a2.1
Interstitial
inflammation
<1
CI <3
Glomerulosclerosis
<0.7
0.7
Interstitial fibrosis
<1
Tubular atropy
<1.05
>1.05
Fibrous crescents
<0.25
0.25
CI increased in five (50%), suggesting that some patients had
ongoing active lupus nephritis, tending towards glomerulosclero-
sis, tubular atrophy, and interstitial fibrosis. Despite this, 14
(70%) of the 20 were clinically better at outcome (that is,
improved by at least one grade), while four (20%) remained
unchanged and only two (10%) became worse. Seven of eight
patients (88%) with a CI < 3 were clinically better and five
(63%) were in grade 1 at outcome. In contrast, only seven of 12
(58%) patients with a CI  3 were clinically better and only two
(17%) were in grade 1 at the outcome. These observations
Table 4. Prognostic value of indices of20 children showing diffuse
proliferative lupus nephritis at first renal biopsy
Number
of
children
9
11
7
13
13
7
14
6
10
10
10
10
10
10
10
10
17
3
11
9
10
I0
4
16
8
12
7
13
7
13
15
5
16
4
Mann—Whitney
U-test
55
53.5
55
46.5
70
56
69
65.5
26.5
55
55.5
48
81
81
72
57
38
P value
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
<0.01
<0.01
<0.05
NS
NS
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support our conclusion that a Cl  3 was significantly predic-
tive of progression (P < 0.01) to a more severe grade (Table 4).
A semi-quantitative scoring system, based on Al and Cl, has
been utilized to a limited extent to analyze renal biopsies of
adults with lupus nephritis [12—161. First, Austin et al [12, 131
studied renal biopsies of 102 lupus patients, of which 72 showed
DPLN or membranoproliferative lupus nephritis. The A!, es-
pecially cellular crescents and fibrinoid necrosis, was found to
be more predictive of progression to renal failure than other
individual histological features of Al. In addition, CI and its
individual histological features, especially tubular atrophy,
were predictive of development of renal failure. Second,
Carette et al [14] assigned a Cl to the renal biopsies of 53 lupus
nephritis patients, most of whom had DPLN. The Ci was useful
in predicting outcome and response to immunosuppressive
therapy, since nine often patients with a high Cl, but only three
of 21 with a low CI, doubled their plasma creatinine levels.
Moreover, of 14 patients with an intermediate CI, one of 11
treated with azathioprine or cyclophosphamide plus prednisone
doubled his plasma creatinine, while all three patients treated
with prednisone alone progressed to end—stage renal failure.
Third, in a study of 62 patients with lupus nephritis who were
treated for more than 18 months with prednisone or cytotoxic
drugs and underwent two renal biopsies, Balow et al [15]found
that Cl increased with time in patients taking prednisone but not
in those taking cytotoxic drugs. They suggested that cytotoxic
drugs reduced the likelihood of developing chronic renal dam-
age in lupus nephritis. It should be noted that the patients
studied in these three previous reports were usually treated at a
very late stage in their disease and consequently often had high
values for Cl. Nevertheless, many of the children described in
the present paper also had high CI values, although their
disease was likely present for a shorter time. Fourth, Magil et al
[16] showed that the total pathologic score (sum of Al and CI)
was not predictive of the development of renal failure in 35
patients with biopsy—proven DPLN. Since values for Al and CI
alone were not shown, the possibility remains that either the A!
or CI was predictive of progression to renal failure but was
negated by the other. Indeed, in the present study, the statisti-
cal significance of the CI for predicting the clinical outcome was
lost when the total pathologic score was used (Table 4).
Many previous studies, both those performed early on and in
recent years, have attempted to draw correlations between the
histological findings seen on a renal biopsy and the clinical
course and outcome of lupus [17—21]. One example is the report
of Hecht et al [221 on 31 patients with SLE, most of whom
underwent repeat renal biopsies. However, these studies were
not performed using a scoring system based on Al and CI.
Nevertheless, most studies have shown that DPLN is a more
serious disease than mesangial or membranous lupus.
Morel—Maroger et al [231 reported that 40 SLE patients with
DPLN, especially those with sclerotic lesions, had a poorer
outcome than lupus patients with minimal glomerular lesions.
Appel et al [7] showed in 56 lupus patients that the WHO
classification of lupus nephritis was the single most important
prognostic indicator. Outcome for patients with mesangial and
membranous lupus was favorable, while that for patients with
DPLN was worse. Finally, in 74 lupus patients, Tateno et al [24]
reported that those whose renal biopsies showed mesangial
lupus or minor changes of DPLN had a benign clinical course.
However, renal function was slightly decreased in patients with
moderate DPLN and markedly abnormal in seven of ten pa-
tients with severe DPLN. Contrary to all of the foregoing
studies, Cameron et al [251 reported no difference in the
outcome of patients with different WHO histological forms of
lupus nephritis. The divergence of opinion reported to date
might be overcome by employing scoring systems of Al and CI
for examining renal biopsies, instead of relying entirely on the
WHO classification.
Most of the children with biopsy—proven DPLN in the
present study were better at outcome than at biopsy; not as
many showed severe proteinuria, none had hematuria or hyper-
tension, the renal status showed improvement, and mean serum
levels of C3 and C4 more than doubled, in addition, extra—renal
manifestations of SLE had almost completely disappeared. This
improvement belies the widely held view that the outcome in
DPLN is usually poor, especially in adults [7]. Furthermore, of
the children undergoing repeat renal biopsies, the four who
converted from DPLN to mesangial or membranous lupus all
showed improvement in Al, emphasizing that A! is reversible.
The fact that CI also fell in two (patients 11 and 13) has been
interpreted as a consequence of the limited size of the renal
biopsies and not necessarily evidence of reversibility.
For some time physicians have argued about the value of
performing renal biopsies in patients with SLE [26]. Biopsies
are traditionally performed for three reasons. First, histological
findings on renal biopsies in patients with lupus nephritis may
change over time. A recent study indicated that the incidence of
conversion from one WHO class to another was high [27].
Second, some patients with lupus nephritis may not show
abnormalities of renal function, although histological examina-
tion of their renal biopsies may show involvement of the
kidneys [28, 29]. Third, qualitative examination of a renal
biopsy using the WHO or modified WHO classifications may
tell the clinician whether a patient with lupus nephritis ought to
be treated with steroids andior cytotoxic drugs and what the
ultimate outcome is likely to be. Based on the findings of the
present study, we suggest that additional information is derived
from performing renal biopsies and examining them semi-
quantitatively by determining the A! and CI. We have shown
that our standard therapy for DPLN of prednisone and
azathioprine could lower the Al, but generally could not reverse
the CI. Although a longer follow—up period is necessary, it
would appear that children with DPLN and a high Cl have a
downward clinical course which is relatively resistant to ther-
apy with steroids and azathioprine. It is too early to say
whether DPLN in these children is resistant to other cytotoxic
drugs. We would suggest that determination of the CI from
renal biopsies may be a useful instrument for helping to predict
therapeutic responses in individual children with DPLN and for
designing prospective clinical trials in this disease.
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